Early pregnancy failure induced by dibutyltin dichloride in mice

Makoto Ema1, Sakiko Fujii, Tsuguo Ikka

  • 1Division of Risk Assessment, Biological Safety Center, National Institute of Health Sciences, Tokyo 185-8501, Japan. ema@nihs.go.jp

Environmental Toxicology
|February 14, 2007
PubMed

Insights

Dibutyltin dichloride (DBTCl) exposure during early pregnancy in mice significantly increases embryonic loss and reduces pregnancy success. This adverse effect is linked to decreased progesterone levels, highlighting DBTCl

Area of Science:

  • Environmental Toxicology
  • Reproductive Toxicology
  • Developmental Toxicology

Background:

  • Environmental contaminants can disrupt reproductive processes.
  • Organotin compounds, like dibutyltin, are known toxicants with potential reproductive effects.

Purpose of the Study:

  • To investigate the adverse effects of dibutyltin dichloride (DBTCl) on pregnancy initiation and maintenance.
  • To determine the impact of DBTCl administration during early pregnancy in mice.

Main Methods:

  • Female ICR mice were administered DBTCl (0, 7.6, 15.2, or 30.4 mg/kg bw/day) via gastric intubation on days 0-3 or 4-7 of pregnancy.
  • Pregnancy outcomes were assessed on day 18, including nonpregnant rates, pre- and postimplantation embryonic loss, and fetal malformations.
  • Serum progesterone levels were measured.

Main Results:

  • DBTCl significantly increased the rate of nonpregnant females and preimplantation embryonic loss at 30.4 mg/kg on days 0-3.
  • Postimplantation embryonic loss increased with DBTCl exposure on days 0-3 (≥15.2 mg/kg) and days 4-7 (≥7.6 mg/kg).
  • A decline in serum progesterone levels was observed at the highest DBTCl dose (30.4 mg/kg) on both administration periods.

Conclusions:

  • DBTCl adversely affects pregnancy initiation and maintenance in mice when administered during early gestation.
  • Reduced serum progesterone levels are suggested to be the mechanism underlying DBTCl-induced pregnancy failure.
  • DBTCl does not appear to cause external fetal malformations at the tested doses.

Related Concept Videos